ONCOLOGY HOLDINGS LTDActive

Company number 10165067Private limited companyIncorporated 2016

Key figures

£589,544+7.7%
Net assets 2024/25
+19.9%
Average annual growth 2019/20–2024/25
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ONCOLOGY HOLDINGS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover26,639—167,011——
Profit for the year19,088—124,896120,937—
Cash at bank and in hand———547,297589,543
Total assets256,700292,259417,155547,298589,544
Total liabilities0000—
Net assets / total equity256,700292,259417,155547,298589,544
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Provision of medical services

As described in the company's latest filed accounts.

Summary: ONCOLOGY HOLDINGS LTD

Company

ONCOLOGY HOLDINGS LTD is a private limited company registered with Companies House under company number 10165067. It was incorporated on 5 May 2016. Its status is active. The registered office is in London (SW19). Its nature of business (SIC 2007) is hospital activities (86101).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files abridged accounts (unaudited). Net assets were £589,544, up 7.7% on the previous year. Cash at bank and in hand was £589,543. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 25 Jun 2027.